#METABOLOMICS WORKBENCH yorch40_20201020_054228 DATATRACK_ID:2217 STUDY_ID:ST001518 ANALYSIS_ID:AN002522 PROJECT_ID:PR001023
VERSION             	1
CREATED_ON             	November 4, 2020, 10:24 am
#PROJECT
PR:PROJECT_TITLE                 	Metabolome analysis in the diagnosis of childhood cerebellar ataxia
PR:PROJECT_SUMMARY               	Metabolome studies to aid in the diagnosis and molecular elucidation of a child
PR:PROJECT_SUMMARY               	presenting chronic progressive cerebellar ataxia and an undiagnosed condition.
PR:INSTITUTE                     	CEMBIO
PR:LAST_NAME                     	Sáiz
PR:FIRST_NAME                    	Jorge
PR:ADDRESS                       	km 0, Universidad CEU-San Pablo Urbanización Montepríncipe, M-501, 28925
PR:ADDRESS                       	Alcorcón
PR:EMAIL                         	jorge.saizgalindo@ceu.es
PR:PHONE                         	0034913 72 47 11
#STUDY
ST:STUDY_TITLE                   	Metabolome analysis in the diagnosis of childhood cerebellar ataxia
ST:STUDY_SUMMARY                 	Metabolome studies to aid in the diagnosis and molecular elucidation of a child
ST:STUDY_SUMMARY                 	presenting chronic progressive cerebellar ataxia and an undiagnosed condition.
ST:INSTITUTE                     	CEMBIO
ST:LAST_NAME                     	Sáiz
ST:FIRST_NAME                    	Jorge
ST:ADDRESS                       	km 0, Universidad CEU-San Pablo Urbanización Montepríncipe. M-501, 28925
ST:ADDRESS                       	Alcorcón
ST:EMAIL                         	jorge.saizgalindo@ceu.es
ST:PHONE                         	913 72 47 11
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_LC_POS	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Plasma_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_LC_NEG	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Plasma_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_GC	Subject:Control	Technique=GC; RAW_FILE_NAME=Control_Plasma_GC
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_CE	Subject:Control	Technique=CE; RAW_FILE_NAME=Control_Plasma_CE
SUBJECT_SAMPLE_FACTORS           	-	Control_Urine_LC_POS	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Urine_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Control_Urine_LC_NEG	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Urine_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Control_Urine_CE	Subject:Control	Technique=CE; RAW_FILE_NAME=Control_Urine_CE
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_LC_POS	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Plasma_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_LC_NEG	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Plasma_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_GC	Subject:Case	Technique=GC; RAW_FILE_NAME=Case_Plasma_GC
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_CE	Subject:Case	Technique=CE; RAW_FILE_NAME=Case_Plasma_CE
SUBJECT_SAMPLE_FACTORS           	-	Case_Urine_LC_POS	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Urine_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Case_Urine_LC_NEG	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Urine_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Case_Urine_CE	Subject:Case	Technique=CE; RAW_FILE_NAME=Case_Urine_CE
#COLLECTION
CO:COLLECTION_SUMMARY            	Metabolite extraction was performed in plasma and urine samples from the patient
CO:COLLECTION_SUMMARY            	and a healthy control, matched for age, sex and weight, according to standard
CO:COLLECTION_SUMMARY            	protocols with some modifications.
CO:SAMPLE_TYPE                   	Blood (plasma)
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Metabolite extraction was performed in plasma and urine samples from the patient
TR:TREATMENT_SUMMARY             	and a healthy control, matched for age, sex and weight, according to standard
TR:TREATMENT_SUMMARY             	protocols with some modifications.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Plasma sample preparation for liquid chromatography–mass spectrometry
SP:SAMPLEPREP_SUMMARY            	(LC–MS) entailed the following steps: (1) thaw sample on ice, vortex for 2 min
SP:SAMPLEPREP_SUMMARY            	and transfer 100 µL of plasma into an Eppendorf tube; (2) for protein
SP:SAMPLEPREP_SUMMARY            	precipitation, add 300 µL of cold (-18˚C) methanol/ethanol (1:1 v/v), vortex
SP:SAMPLEPREP_SUMMARY            	for 1 min, incubate on ice for 5 min and vortex again briefly; (3) centrifuge at
SP:SAMPLEPREP_SUMMARY            	13000 rpm, 4˚C, for 20 min; and (4) transfer the supernatant into the LC–MS
SP:SAMPLEPREP_SUMMARY            	system. Plasma sample preparation for gas chromatography–mass spectrometry
SP:SAMPLEPREP_SUMMARY            	(GC–MS) entailed the following steps: (1) thaw sample on ice, vortex for 2 min
SP:SAMPLEPREP_SUMMARY            	and transfer 40 µL of plasma into an Eppendorf tube; (2) for protein
SP:SAMPLEPREP_SUMMARY            	precipitation, add 120 µL of cold acetonitrile, vortex for 2 min and incubate
SP:SAMPLEPREP_SUMMARY            	on ice for 5 min; (3) centrifuge at 15400 rpm, 4˚C, for 10 min; and (4)
SP:SAMPLEPREP_SUMMARY            	transfer the supernatant into a GC vial with insert; (5) evaporate in a Speedvac
SP:SAMPLEPREP_SUMMARY            	at 30°C until dry; (6) add 10 µL of O-methoxyamine hydrochloride (15 mg/mL) in
SP:SAMPLEPREP_SUMMARY            	pyridine and vortex for 5 min; (7) sonicate for 2 min and vortex for 2 min
SP:SAMPLEPREP_SUMMARY            	(repeat step a total of three times); (8) incubate at room temperature for 16 h
SP:SAMPLEPREP_SUMMARY            	in darkness for the reaction of the methoxymation; (9) add 10 µL of
SP:SAMPLEPREP_SUMMARY            	N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1 % trimethylchlorosilane
SP:SAMPLEPREP_SUMMARY            	(TMCS) and incubate 1 h at 70 ˚C for the silylation; (10) add 100 µL of 10 ppm
SP:SAMPLEPREP_SUMMARY            	C18:0 methyl ester in n-heptane as internal standard, vortex for 2 min and
SP:SAMPLEPREP_SUMMARY            	centrifuge at 2500 rpm, 20˚C, for 15 min; and (11) transfer into the GC–MS
SP:SAMPLEPREP_SUMMARY            	system. Plasma sample preparation for capillary electrophoresis–mass
SP:SAMPLEPREP_SUMMARY            	spectrometry (CE–MS) entailed the following steps: (1) thaw sample on ice,
SP:SAMPLEPREP_SUMMARY            	vortex for 1 min and transfer 100 µL of plasma into an Eppendorf tube already
SP:SAMPLEPREP_SUMMARY            	filled with 100 µL of 0.2 M formic acid with 5 % acetonitrile and 0.4 mM
SP:SAMPLEPREP_SUMMARY            	methionine sulfone as internal standard; (2) vortex for 2 min and transfer to a
SP:SAMPLEPREP_SUMMARY            	Millipore filter (30 kDa protein cutoff); (3) centrifuge at 2000 rpm, 4˚C, for
SP:SAMPLEPREP_SUMMARY            	70 min; and (4) transfer the filtrate into a CE vial where the volume is
SP:SAMPLEPREP_SUMMARY            	directly injected into the CE–MS system. Urine samples for LC–MS were thawed
SP:SAMPLEPREP_SUMMARY            	on ice and vortexed prior injection into the LC-MS system (without
SP:SAMPLEPREP_SUMMARY            	pre-treatment). For CE–MS, sample procedure entailed: (1) thaw on ice and
SP:SAMPLEPREP_SUMMARY            	vortex for 1 min and transfer 200 µL into an Eppendorf tube; (2) centrifuge at
SP:SAMPLEPREP_SUMMARY            	13200 rpm, 4˚C, for 20 min; (3) transfer 100 µL of the supernatant into an
SP:SAMPLEPREP_SUMMARY            	Eppendorf tube already filled with 400 µL of 0.125 M formic acid with 0.25 mM
SP:SAMPLEPREP_SUMMARY            	methionine sulfone as internal standard; (4) vortex for 1 min and centrifuge at
SP:SAMPLEPREP_SUMMARY            	13200 rpm, 4˚C, for 10 min; and (5) transfer 200 µL of the supernatant into a
SP:SAMPLEPREP_SUMMARY            	CE vial where the volume is directly injected into the CE–MS system. Quality
SP:SAMPLEPREP_SUMMARY            	control (QC) samples were independently prepared for each technique and followed
SP:SAMPLEPREP_SUMMARY            	the same procedure as applied for experimental samples. QC samples were always
SP:SAMPLEPREP_SUMMARY            	injected at the beginning of each analytical run, followed by samples randomized
SP:SAMPLEPREP_SUMMARY            	independently. A QC sample was rerun after each block of 5 samples.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Positive ionization
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	Discovery® HS C18 (15 cm x 2.1 mm x 3 µm)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6520 QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	None
MS:MS_RESULTS_FILE               	ST001518_AN002522_Results.txt	UNITS:area	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END